Loutradis Dimitris
The exploitation of pharmaceutical innovation has resulted in a 15 – 24% reduction in mortality from malignant diseases worldwide, helping to save resources and ensure productivity by reducing hospitalizations and lost working days. There are currently a large number of new drugs under development aiming at some of the most serious health problems, and the crucial question that arises is: will the patients and the health system in Greece be able to benefit from this huge stream of innovation …